Manchester patients have been quick to notice the news. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK the first country in Europe to approve this once-daily GLP-1 weight loss tablet. For a city that has embraced weight loss injections like Mounjaro and Wegovy so enthusiastically over the past few years, it is no surprise that our phones have been ringing with the same question: can I get Foundayo in Manchester, and when?
As a pharmacy based at the heart of Whalley Range, with branches across Chorlton, Grove Village and beyond, Everest Pharmacy has supported thousands of Manchester patients through their weight loss journeys, from initial consultations right through to long-term maintenance. We are now preparing to add Foundayo to the treatments we offer, working alongside our online partner platform, Everslim, so that Manchester patients are among the first in the country to access it once it launches.
This guide explains exactly what Foundayo is, why its UK authorisation matters, what it means for patients in Manchester specifically, and how to register your interest ahead of launch. If you would like to speak to someone directly, contact our team today.
What Is Foundayo (Orforglipron)?
Foundayo is the UK brand name for orforglipron, a GLP-1 receptor agonist developed as a once-daily tablet rather than an injection. It works in a broadly similar way to existing GLP-1 treatments such as semaglutide and tirzepatide, by mimicking a natural gut hormone that helps regulate appetite, slow digestion, and support a feeling of fullness after eating.
What makes Foundayo different from many patients’ existing experience of GLP-1 treatment is the format. Rather than a weekly injection pen, Foundayo is taken as a tablet, opening this type of treatment up to Manchester patients who have previously avoided GLP-1 medicines specifically because of needle anxiety, or who simply prefer the convenience of a pill they can take at home, at work, or while travelling.
Why The UK Authorisation Matters For Manchester Patients
The MHRA’s decision to authorise orforglipron on 10 August 2026 is significant well beyond the headlines. It means the medicine has been formally assessed and approved to the UK’s regulatory standards for safety, quality and effectiveness, ahead of any other country in Europe.
For Manchester specifically, this matters because our city has become one of the UK’s most active hubs for private weight loss treatment. Demand for Mounjaro and Wegovy across areas like Whalley Range, Chorlton and the wider Greater Manchester region has been consistently high, and many patients locally have already asked us directly whether an oral GLP-1 option might suit them better than an injection. Foundayo’s UK authorisation is the first step towards making that a reality here.
Following approval, providers, including Everest Pharmacy, now need to finalise supply arrangements and clinical pathways before Foundayo can actually be prescribed. We are working through this process now, with the aim of bringing it to Manchester patients as soon as it is responsibly possible.
How Does Foundayo Work?
Like other GLP-1 receptor agonists, Foundayo works by targeting receptors involved in appetite regulation and digestion. In practical terms, this means it can help by:
-
- Reducing overall appetite and food-related cravings
- Slowing the rate at which food leaves the stomach, extending feelings of fullness
- Supporting the brain’s natural signals of satisfaction after eating
- Helping regulate blood sugar, which is why it has also been authorised for type 2 diabetes
Foundayo is intended to be used alongside a reduced-calorie diet and increased physical activity, in the same way as other prescription weight loss treatments. It is not designed to work as a standalone solution, and any Manchester patient considering it should expect a treatment plan that includes lifestyle guidance alongside the medicine itself.
Foundayo Compared To Existing GLP-1 Options In Manchester
Many patients across Manchester will already be familiar with Mounjaro and Wegovy, both of which we currently offer through our branches. Here is how Foundayo is expected to compare once it launches.
| Feature | Foundayo (Orforglipron) | Wegovy (Semaglutide) | Mounjaro (Tirzepatide) |
|---|---|---|---|
| Form | Oral tablet | Injection or newer oral pill | Injection |
| Frequency | Once daily | Once weekly (injection) or once daily (pill) | Once weekly |
| Mechanism | GLP-1 receptor agonist | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| Current Manchester availability | Available from 24th August | Available now via Everest Pharmacy | Available now via Everest Pharmacy |
| Needle-free | Yes | Injection version: no. Pill version: yes | No |
It is too early to give a definitive answer on how Foundayo’s effectiveness will compare to Mounjaro and Wegovy in UK patients specifically, as real-world data is still emerging. If you are currently weighing up your options in Manchester, our detailed comparison of Mounjaro vs Wegovy is a useful place to start.
Who Is Eligible For Foundayo In Manchester?
Eligibility assessments will be similar to how we currently assess patients for existing GLP-1 treatments, and will consider:
-
- Your current BMI and weight history
- Any existing health conditions, including diabetes, heart or kidney conditions
- Current medications and any potential interactions
- Whether you have used GLP-1 treatment before, and how you responded to it
- Whether you are pregnant, breastfeeding, or planning a pregnancy
As with Mounjaro and Wegovy, Foundayo is not suitable for everyone, and eligibility can only be confirmed through a proper clinical assessment rather than judged from general guidance online.
Everest Pharmacy’s Manchester Branches
Everest Pharmacy is based at our Whalley Range head office, with branches across Chorlton and Grove Village, alongside our sister branch in Darwen. Patients across these areas, and the wider Greater Manchester region, have relied on us for private weight loss consultations, prescriptions and ongoing support for several years.
Foundayo is available in clinic and through our online partner platform, Everslim, for patients who prefer a fully remote consultation and home delivery. This means Manchester patients have the choice of an in-person assessment locally or a convenient online route, depending on what suits them best.
How To Register Your Interest In Foundayo
Because Foundayo has only just been authorised, the most useful thing Manchester patients can do right now is register interest so they are notified the moment it becomes available via Everslim, rather than waiting to hear about it after launch. You can do this by:
-
- Registering your interest directly on the Foundayo product page on Everslim
- Contacting our Manchester team to ask about being notified when assessments open
- Asking about your eligibility for currently available treatments while you wait, so you are not delaying your weight loss journey unnecessarily
If you are new to GLP-1 treatment generally and want to understand more about how these medicines work before deciding, our article on how semaglutide works covers the underlying science in more depth.
What A Foundayo Assessment Involves
A Foundayo consultation at Everest Pharmacy will follow a similar structure to our existing weight loss assessments online with Ererslim. This typically includes a review of your medical history, current medications, weight goals and any relevant risk factors, followed by a decision from a prescribing clinician on whether Foundayo is a suitable option for you.
Patients who are approved will receive clear guidance on how to take the tablet, what to expect during the first few weeks, and how progress will be monitored over time. As with any weight loss treatment we offer, ongoing support is a core part of the process rather than a one-off prescription handed over without follow-up.
Safety Considerations For Foundayo
As with other GLP-1 medicines, Foundayo is not suitable for everyone. Based on the wider GLP-1 medicine class, it is likely to carry similar cautions to Mounjaro and Wegovy, including for patients with certain thyroid conditions, a history of pancreatitis, or significant digestive conditions. Common side effects associated with GLP-1 medicines generally relate to the digestive system, particularly nausea, and tend to be more noticeable during the early stages of treatment.
Because Foundayo is newly authorised, UK-specific safety monitoring is still in its early stages. Any Manchester patient starting treatment in future will be given up to date, medicine-specific safety information directly by their prescribing clinician at the point of assessment.
Why Manchester Patients Are Particularly Interested In Foundayo
A few factors explain why interest in Foundayo has been especially strong across Manchester specifically:
-
- High existing demand for GLP-1 treatment: Manchester has one of the highest concentrations of private weight loss patients in the North West, meaning any new oral GLP-1 option is likely to attract significant local interest.
- A needle-free alternative: Many Manchester patients who have previously avoided Mounjaro or Wegovy specifically because of the injection have been asking us directly about tablet-based alternatives.
- Convenience for busy lifestyles: With no strict food or water timing requirements reported for Foundayo, it may suit Manchester patients balancing demanding work schedules, shift patterns or frequent travel.
- Trusted local access: Patients already know and trust Everest Pharmacy for weight loss treatment across Whalley Range, Chorlton and Grove Village, making it a natural first port of call once Foundayo becomes available.
If you would like to compare GLP-1 tablets currently available in Manchester while Foundayo prepares to launch, read our guide on 2026 oral weight loss options and availablity.
What To Do While Waiting For Foundayo To Launch
If you are ready to start weight loss treatment now, waiting for Foundayo may not be the most practical option, as an exact launch date has not yet been confirmed. In the meantime, our Manchester team can assess you for currently available, MHRA-licensed treatments, including:
-
- Mounjaro (tirzepatide), one of the most effective GLP-1 treatments currently available
- Wegovy injection (semaglutide), a well-established option with a strong track record among Manchester patients
- The Wegovy pill (oral semaglutide), already available as a needle-free tablet option through Everest Pharmacy
Starting with one of these options now does not prevent you from discussing Foundayo with us in future, once it becomes available and your prescriber can assess whether switching or continuing your current treatment is the right approach for you.
Book A Consultation At Everest Pharmacy
Whether you want to be among the first Manchester patients to access Foundayo, or you would rather start your weight loss journey today with a currently available treatment, our team is here to guide you through the options, both in clinic and online. We take the same careful, clinically led approach to every treatment we offer, and we will always be upfront with you about what is genuinely available now versus what is still on the way.
Contact our Manchester team today to discuss your options, or explore our full weight loss services page for more information.
Frequently Asked Questions
Is Foundayo currently available at Everest Pharmacy in Manchester?
Foundayo was authorised by the MHRA on 10 August 2026, and became available via private prescription in UK pharmacies on 24 August, although it is not yet available via the NHS, and we are finalizing details ahead of an official launch.
Can I get an in-person consultation for Foundayo in Manchester, rather than online?
Yes, once launched. Patients will be able to choose between an in-person assessment at one of our Manchester branches or a remote consultation through Everslim, depending on personal preference.
Will Manchester patients get priority access to Foundayo?
Registering your interest in advance is the best way to be notified as soon as assessments open, wherever you are based.
Is Foundayo likely to cost more or less than Mounjaro or Wegovy in Manchester?
Pricing for Foundayo will begin at £109 through Everslim. Our Manchester team will be able to guide you through cost and need in a consultation.
Can I switch from Mounjaro or Wegovy to Foundayo in Manchester?
This will be assessed individually by a prescribing clinician, taking into account your current dose, treatment response and overall health.
What should I do if I want to start weight loss treatment in Manchester today?
You do not need to wait for Foundayo. Our Manchester team can assess your eligibility for treatments such as Mounjaro, Wegovy injection, or the Wegovy pill too.
Stay Ahead With Everest Pharmacy
Foundayo’s UK authorisation is an important milestone for weight loss treatment, and Manchester patients are well placed to be among the first to access it once it launches. Whether you are ready to register your interest or would prefer to start with a currently available treatment, our team is here to support you every step of the way.
Contact us today, or book an appointment at one of our Manchester branches to discuss your options.